Discover
CNTB
Connect Biopharma Holdings Limited
2.39
2 x 1.78
2 x 3.03
bid
ask
+
0.01
0.42%
2 @ 04:00 AM
2.46 +0.07 (2.93%)
| Ytd | -15.25% | |
| 1y | 125.47% |
2.34
day range
2.51
1.02
52 week range
3.82
| Open | 2.45 | Prev Close | 2.38 | Low | 2.34 | High | 2.51 | Mkt Cap | 150.48M |
| Vol | 375.95K | Avg Vol | 318.82K | EPS | -1.15 | P/E | N/A | Forward P/E | -5.04 |
| Beta | -0.31 | Short Ratio | 1.93 | Inst. Own | 44.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-19 | 50-d Avg | 2.32 | 200-d Avg | 2.34 | 1yr Est | 7.00 |
| Income Statement | |||
| Total Revenue | 169.00K | ||
| Revenues (USD) | 169.00K | ||
| Gross Profit | 169.00K | ||
| Operating Expenses | 19.78M | ||
| Research and Development Expense | 15.03M | ||
| Selling, General and Administrative Expense | 4.75M | ||
| Operating Income | -19.61M | ||
| Income Tax Expense | 48.00K | ||
| Net Income | -19.40M | ||
| Net Income Common Stock | -19.40M | ||
| Net Income Common Stock (USD) | -19.40M | ||
| Consolidated Income | -19.40M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -19.35M | ||
| Earning Before Interest & Taxes (USD) | -19.35M | ||
| Weighted Average Shares | 56.55M | ||
| Weighted Average Shares Diluted | 56.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 46.03M | ||
| Cash and Equivalents (USD) | 46.03M | ||
| Current Assets | 55.02M | ||
| Property, Plant & Equipment Net | 4.36M | ||
| Total Assets | 60.07M | ||
| Debt Current | 406.00K | ||
| Total Debt | 693.00K | ||
| Current Liabilities | 17.05M | ||
| Debt Non-Current | 287.00K | ||
| Total Liabilities | 17.44M | ||
| Accumulated Retained Earnings (Deficit) | -420.23M | ||
| Accumulated Other Comprehensive Income | -1.06M | ||
| Shareholders Equity | 42.62M | ||
| Shareholders Equity (USD) | 42.62M | ||
| Assets Non-Current | 5.05M | ||
| Total Debt (USD) | 693.00K | ||
| Goodwill and Intangible Assets | 43.00K | ||
| Liabilities Non-Current | 398.00K | ||
| Trade and Non-Trade Payables | 4.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 164.00K | ||
| Net Cash Flow from Financing | 17.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.69M | ||
| Issuance (Purchase) of Equity Shares | 17.62M | ||
| Net Cash Flow from Investing | 6.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.00M | ||
| Net Cash Flow from Operations | -16.00M | ||
| Effect of Exchange Rate Changes on Cash | 72.00K | ||
| Share Based Compensation | 1.20M | ||